Last week Pixels & Pills’ editor Briana Campbell had the pleasure of sitting down for a Skype chat (so the quality is a little lower than our normal, professional videos) with Dr. Darshan Kulkarni (@FDALawyers) of the Kulkarni Law Firm in Philadelphia. And while the questions answered in the conversation don’t constitute legal advice and [...]
Tags:#hcsm·@FDALawyers·Darshan Kulkarni·FDA·FDA Guidance·information·innovation·legal·Legal Issues·marketing·resources·social media·social media guidance·social media guidelines·Trends·Video
by Briana Campbell (@MsMatchGirl)
Just the other day Richard Meyer posted an article entitled, “STOP! Social Media Is Not the Answer” in which he makes a strong case against pharma marketers turning to social media for their campaigns. He points out that people don’t want to connect with their drugs on social networks. He points out [...]
Tags:#hcsm·Facebook·Google·LinkedIn·marketing·Pharma·pharma marketing·Pharmaceutical industry·social·social media·Social network·social networking·Twitter
by Briana Campbell (@MsMatchGirl)
Wrath. Sloth. Greed. Gluttony. Lust. Envy. Pride.
The seven deadly sins.
In June of this year, PM360 laid out the Seven Deadly Sins of Pharma Marketing (you can take a peek at the digital edition here). And Dave Sonderman laid out his accompanying thoughts on the unintentional sins in a post on the GSW [...]
Tags:#hcmktg·#hcsm·communication·Communities·community·digital strategy·Digital Tools·Education·Facebook·FDA·Health·Health care·healthcare·information·marketing·Pharmaceutical industry·social media·social media platforms·social media strategies·Social network·strategy·Trends·Twitter
by Briana Campbell (@MsMatchGirl)
There has been a lot of talk, over the past few months, over Facebook’s changing commenting policies and the pharma industry. Our friend Jonathan Richman clears things up nicely on Dose of Digital, so we won’t bother going into too much detail here. Basically, though, Facebook has changed its policy regarding comments [...]
Tags:#hcsm·communication·Facebook·FDA·innovation·Legal Issues·marketing·Pharma·Pharmaceutical industry·social media·Social network·tools
By Jim Mittler, PhD, Medical Director (@jim_mittler)
We all know that the social media revolution is happening and it cannot be stopped—this is according to the exponential growth of social media over the past several years. It has fundamentally changed the way in which information is disseminated and the way people communicate throughout the world today. [...]
Tags:#fdasm·#hcsm·American Recovery and Reinvestment Act of 2009·communication·Communities·Digital divide·digital strategy·drug safety·Education·Facebook·Health care·Health Care Reform·innovation·Legal Issues·mobile·patient portal·Patients·Pharmaceutical industry·social media·technology·United States·WebMD·YouTube
